Discussion on Drug Reevaluation by Analyzing Adverse Drug Reaction of Traditional Chinese Medicine Injection

Xiao-ju BAI

DOI: https://doi.org/10.3969/j.issn.1672-8629.2009.02.005

2009-01-01

Abstract:By analyzing the characteristics on adverse drug reaction of Traditional Chinese Medicine(TCM)injection,to discuss drug reevaluation from component,safety of drug,efficiency,pharmacoeco-nomics,quality criteria and drug combination.

What problem does this paper attempt to address?

[Analysis on the Common Causes for Traditional Chinese Medicinal Injection Induced Adverse Reactions and the Preventive Countermeasures].

Guo-lin Wu,Li Zhang,Guo-you Yu

DOI: https://doi.org/10.3321/j.issn:1003-5370.2008.12.031

2008-01-01

Abstract:As a new dosage form, TCM injection is commonly used in clinical practice. But the increasing events of adverse drug reactions (ADRs) could even seriously endanger patients' lives. The causes of TCM injection inducing ADRs might be the unstable quality of preparation; the irrational clinical use and operation; the sensitive physique of patient and the change of patients' primary illness, etc. For preventing the occurrence of ADRs, based on guaranteeing the stable quality of product, putting stress on accurate usages and normalized operations in clinical practice, enhancing the monitor on ADRs and the precautionary awareness in medical units are very important.
[Retrospective Analysis and Discussion on 74 Cases of Adverse Reactions of Traditional Chinese Medicine Injection].

Yan Wang,Li-Ping Fan,Ju Song,Yue-Ping Cai,Ting-Ting Jinang,Yu-Guang Wang,Xiang-Wen Kong,Jia-Rui Wu

DOI: https://doi.org/10.19540/j.cnki.cjcmm.20180815.004

2018-01-01

Abstract:As a modern dosage form drug with rapid effect, traditional Chinese medicine (TCM) injection has been more and more used in clinical practice. Meanwhile the safety of TCM injection has attracted more and more attention. The retrospective analysis on 74 cases of adverse reaction of TCM injections collected from 2007 to 2016 in the Third Affiliated Hospital of Beijing University of Chinese Medicine showed that the proportion of men and women with adverse reactions was 0.54:1; the average age was 62.5 years old; 21 kinds of TCM injections were involved. Among them, the most reported were blood-regulating agents. The top four kinds of TCM injections with highest adverse drug reactions (ADRs) were Tanreqing injection, Danhong Injection, Shuxuening Injection and Xuesaitong for injection. The top three clinical manifestations of adverse reactions were lesions of skin and its appendages, damage of circulatory system and damage of nervous system. The potential causes of the adverse reactions of TCM injections were analyzed, and it was believed that individual difference, medicine, pharmaceutical excipients, solvent and TCM syndrome differentiation may be the main five causes for the adverse reactions of TCM injections. In order to reduce the adverse reactions of TCM injections, it is suggested that the clinical pharmacists should participate in the application management of TCM injections in the hospital; the production enterprises shall strengthen the whole life cycle management of the drugs; and at the same time, the drug control and administration authorities should improve the drug management methods constantly and encourage the development of TCM injections to the high quality level.
Thinking on Strengthening the Study of Adverse Drug Reaction of Traditional Chinese Medicine

Xiao-ju BAI

DOI: https://doi.org/10.3969/j.issn.1672-8629.2009.07.004

2009-01-01

Abstract:By analyzing the factors on adverse drug reaction(ADR) of Traditional Chinese Medicine(TCM), to discuss how to strengthen the study on ADR of TCM.
Discriminant Analysis of "Q-Markers" of Traditional Chinese Medical Injections——Taking Dan Hong Injection as a Model

Jing Yang,Zhenzuo Jiang,Xin Chai,Yi Wang,Buchang Zhao,Xiaoping Zhao,Yuefei Wang

DOI: https://doi.org/10.11842/wst.2016.12.005

2016-01-01

Abstract:Quality control of traditional Chinese medicine is of great importance to ensure its safety and effectiveness in clinic,and is also an obstacle impeding the modernization of traditional Chinese medicine.Though,the complexity of traditional Chinese medicine resulted in some relative weakness of quality standard researches.The critical point need addressing is to establish a sound quality standard system conforming to the characteristics of traditional Chinese medicine in the process of the modernization of Chinese medicine.In this paper,in regard to Dan Hong injection,discriminant strategy of "Q-Markers" from traditional Chinese medicine injection was clarified from three aspects:what ingredients,which to control and how to control,providing a new vision in the field of the quality standard researches of traditional Chinese medicine.
Discussion on Strengthening Management of Traditional Chinese Medicine Injection

Zhang Hongdong

DOI: https://doi.org/10.3969/j.issn.1006-2882.2011.02.039

2011-01-01

Abstract:In recent years,Injection-induced serious adverse reactions to Tuxingcao injection,Ciwujia injection,Yinzhihuang injection and so on have entered the public view one after another.How can we prevent the adverse reactions occurring The reasons for security accidents in Chinese medicine injection are non-standard clinical application,non-symptomatic medication,drug overdose and combination with westem medicine.This phenomenon is widespread in clinical practive.We must be cautious about using traditional Chinese medicine injections to the spelialpopulation(suchas newborns) to standardize and improve the quality standard of related drugs is the key.
["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations]

Shu-Xin Wu,Hong-Feng Sun,Xiao-Hui Yang,Hong-Zhu Long,Zu-Guang Ye,Shao-Liang Ji,Li Zhang

Abstract:We revisited the "Xiao Chaihu Decoction event (XCHDE)" occurred in late 1980s in Japan and the Bupleuri Radix related adverse drug reaction (ADR) reports in China After careful review, comparison, analysis and evaluation, we think the interstitial pneumonitis, drug induced Liver injury (DILI) and other severe adverse drug envents (ADEs) including death happened in Japan is probably results from multiple factors, including combinatory use of XCHDE with interferon, Kampo usage under modern medicine theory guidance, and use of XCHD on the basis of disease diagnosis instead of traditional Chinese syndrome complex differentiation. There are less ADE case reports related to XCHD preparation in China compared to Japan, mostly manifest with hypersensitivity responses of skin and perfuse perspiration. The symptoms of Radix Bupleuri injection related ADEs mainly manifest hypersensitivity-like response, 2 cases of intravenous infusion instead of intramuscular injection developed hypokalemia and renal failure. One case died from severe hypersensitivity shock. In Chinese literatures, there is no report of the interstitial pneumonitis and DILI associated with XCHDG in Japan. So far, there is no voluntary monitoring data and large sample clinical research data available. The author elaborated the classification of "reevaluation" and clarified "re-evaluation upon events" included the reaction to the suspected safety and efficacy events. Based on the current status of the clinical research on the Radix Bupleuri preparations, the author points out that post-marketing "re-evaluation upon suspected event" is not only a necessity of continuous evaluation of the safety, efficacy of drugs, it is also a necessity for providing objective clinical research data to share with the international and domestic drug administrations in the risk-benefit evaluation. It is also the unavoidable pathway to culture and push the excellent species and famous brands of TCM to the international market, in that it enhances the pharmaceutical manufactures the ability to control enterprise risk and eliminate the negative impact on traditional Chinese medicine. With the widely used and ADR report concentrated Radix Bupleuri injection as an example, the author provide a new approach to post-marketing clinical research.
Advances in analytical techniques and quality control of traditional Chinese medicine injections

Yujia Tu,Linnan Li,Zhengtao Wang,Li Yang

DOI: https://doi.org/10.1016/j.jpba.2021.114353

IF: 3.571

2021-11-01

Journal of Pharmaceutical and Biomedical Analysis

Abstract:Traditional Chinese medicine injections (TCMIs) are a new pharmaceutical form in the modernization of traditional Chinese medicines (TCMs). Its efficacy is rapid, the curative effect is improved, and is widely used in critical and acute diseases, complicated and severe diseases, and other treatment. However, with the broad applications of TCMIs, clinical adverse reactions frequently occur, and safety problems become more prominent. Therefore, the quality control of TCMIs is essential. Chemical analysis methods and biological analysis methods are widely used in the quality control of TCMIs. This article describes the current status of TCMIs, the analytical techniques, and methods currently used, and the quality control of TCMIs. A summary of the advantages and disadvantages of the current analysis methods is presented. An overview of the quality control of TCMIs is introduced. In addition, emerging techniques of the quality control of TCMIs are introduced.

pharmacology & pharmacy,chemistry, analytical
Implementation of Quality by Design in the Program of Safety Re-evaluation of TCM Injections

Liu Li,Qu Haibin

DOI: https://doi.org/10.11842/wst.2013.06.034

2013-01-01

Abstract:It has been widely accepted in modern pharmaceutical industry that quality cannot be tested into products , instead quality should be built-in by design . However , the implementation of Quality by Design ( QbD ) in development , manufacture and supervision of traditional Chinese medicine ( TCM ) still remains to be a challenge . The program of safety re-evaluation of TCM injections provides an opportunity to practice QbD approach in TCM industry . This paper discussed some potential ways that improve the quality of TCM injec-tions base on QbD related tools , including identification of critical quality attributes , critical process parameters and critical material attributes, development of design space and control strategy.
Analysis of 136 ADRs Induced by Chinese Patent Medicine

CUI Xiao-rong,SHI Chun-sheng,GONG Shu-yan

2011-01-01

Abstract:OBJECTIVE:To learn the characteristics and related factors of adverse drug reactions(ADR) of Chinese pateat medicine,and to provide reference for rational use of drugs in the clinic.METHODS:136 ADRs collected from our hospital during Jan.2007～Jun.2010 were analyzed retrospectively in respect of patient' age and gender,route of administration,drug category and clinical manifestation of ADRs.RESULTS:A total 136 cases involved 41 kinds of drugs.TCM injection caused 119 ADR cases,involving 26 kinds.The main types of drugs which induced ADRs were cardiovascular disease drugs.Main clinical manifestations were lesion of skin and its appendants.CONCLUSION:Great importance should be attached to ADRs induced by Chinese patent medicine.Traditional Chinese Medicine injection should be used carefully in order to improve rational drug use in the clinic.
Discussion on the Factors Influencing the Safety of Injections

HAO Li-zhi,SHI Chun-sheng,GONG Shu-yan

DOI: https://doi.org/10.3969/j.issn.1672-2809.2012.14.010

2012-01-01

Abstract:Through the investigation of nearly four year adverse reaction reports in our hospital,causes of injection induced adverse reactions were summarized and the influential factors analyzed.By Investigating the source of injection induced adverse reactions,reference was made to help avoid and resolve injection induced adverse drug reactions.Anti-infective drugs and traditional Chinese medicine injections had high incidence of adverse reactions.The production conditions,excessive use and irrational use were the main reasons.The use of injections needs to be further standardized to reduce the incidence of adverse reactions.
Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China

Haona Li,Jianxiong Deng,Lewen Deng,Xuequn Ren,Jielai Xia

DOI: https://doi.org/10.1002/pds.4805

2019-05-27

Pharmacoepidemiology and Drug Safety

Abstract:<h3> Purpose</h3><p>Although a series of serious adverse events have continually raised concerns about the potential toxicity of traditional Chinese medicine injections (TCM injections), studies on this subject are still sparse. We conducted a descriptive analysis of a spontaneous reporting system in China to describe the safety profile of TCM injections.</p><h3> Methods</h3><p>The safety profile of TCM injections is described by descriptive analysis of 559 066 adverse reports collected from Guangdong Provincial Center for adverse drug reaction (ADR) Monitoring in China during 2003 to 2017.</p><h3> Results</h3><p>The percentage of new or serious ADRs of TCM injections is much higher than average percentage of China's spontaneous reporting system (SRS) as a whole (48.70% vs <25%). Compared with conventional injections, TCM injections have a slightly lower percentage of serious ADRs (6.02% vs 6.72%) and much higher percentage of unknown (new) ADRs (46.74% vs 24.13%). The gender and age distribution for TCM injections are similar to conventional injections. The reporting rates of ADRs increased with age. Anaphylactic shock and anaphylactoid reaction are high‐risk ADRs for TCM injections and, anaphylactic shock is ranked number 1 in causing deaths (50.00%).</p><h3> Conclusions</h3><p>There are some differences and similarities on the safety profile between TCM injections and conventional injections. TCM injections have higher risk of adverse effects than any other dosage forms of TCM medications and higher percentage of new or serious adverse effects than conventional injections. A lot of work need to be done to clarify the huge amount of potential unknown adverse effects related to TCM injections.</p>

pharmacology & pharmacy,public, environmental & occupational health
[Application status and safety countermeasures of traditional Chinese medicine injections]

Xing-jiang Xiong,Jie Wang,Qing-yong He

DOI: https://doi.org/10.3736/jcim20100402

Abstract:The research and development of traditional Chinese medicine (TCM) injections is an important innovation of modernization of TCM, which has great clinical value and irreplaceability in medical enterprise of China. But reports of adverse events of TCM injections gradually increased in recent years and the security problems received much concern with the enlargement of its application range. The reasons include unreliable herb sources and unreasonable utilization, in which the former includes historical reasons and non-unified standard and the latter includes combined use of Chinese and Western medicine, misused dosage and formula not corresponding to syndromes. We should face the problems, and preventive measures should be worked out by pharmaceutical factory, doctors and government. The first one is strictly guarding the pharmaceutical preparation procedures with advanced pharmaceutical technology; the second one is advocating the idea of formula corresponding to syndromes to minimize the occurrence of adverse effects; and the last one is strengthening the postmarketing reevaluation and market supervising management.
Analysis and Discussion on Instruction of Traditional Chinese Medicine Injection

白晓菊,于妮娜,张志芬

DOI: https://doi.org/10.3969/j.issn.1672-8629.2009.05.005

2009-01-01

Abstract:The safety of Traditional Chinese Medicine(TCM) injection has been pay close attention,how to use TCM injection safely and rationally is an urgent problem.Instruction is the evidence for safety use of drug,it's also the directory for management of drug.By analyzing problems of the instruction of TCM injection to give some suggestions and countermeasure.
Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China

Rui Huang,Yuanxuan Cai,Linhui Yang,Xiaofang Shangguan,Bishwajit Ghose,Shangfeng Tang

DOI: https://doi.org/10.1038/s41598-021-88339-9

IF: 4.6

2021-04-23

Scientific Reports

Abstract:Abstract Traditional Chinese medicine (TCM) injection is widely used in clinical settings, but its adverse drug reactions (ADRs) can be a serious public health concern. The objective is to study the safety of TCM injection and provide suggestions for clinical use. ADR reports collected by the Hubei Adverse Drug Reaction Monitoring Center from 2014 to 2019 were analysed. The safety of TCM injections was described by descriptive analysis and three signal mining methods, including the reporting odd ratio (ROR), proportional reporting ratio (PRR) and comprehensive standard method (MHRA). The findings indicate that the age groups of 0–10 and 41–80 years had the highest rates of reporting ADRs. A total of 96.41% of the ADRs occurred within one week, mostly on the same day that the injection was administered. Among the 60 TCM injections, Shenmai, Xiangdan, Salvia, Shengmai, Astragalus and Xuebijing injection had an above average ratio of severe ADRs (12.63%). A total of 99.24% of the cases improved after treatment. There were 9 deaths whose ADRs were mainly anaphylactic shock, dyspnoea and anaphylactoid reaction. In signal mining, the three methods produced 19 signals that were the same, and 14 of them were off-label ADRs. The frequency of TCM injections in children and elderly patients should be reduced and monitored strictly. Close observation is necessary during the first seven days after receiving the injection. The clinical use of Shenmai, Xiangdan, Salvia, Shengmai, Astragalus and Xuebijing injections should be investigated. Signal mining and more research are needed on TCM injections.

multidisciplinary sciences
The Analysis and Evaluation of Adverse Reactions Caused by TCM Decoction

梁志齐,毛璐

DOI: https://doi.org/10.3969/j.issn.1005-9903.2010.09.070

2010-01-01

Abstract:Objective: To define the present situation of adverse reactions of traditional Chinese medicine(TCM) decoction based on references in recent 30 years.Method: The case reports of adverse reaction caused by TCM decoction were collected from medical literature.Result: The case reports were increased in recent years.Thirty one cases were reported in 25 literatures.In the all cases about 32.25% were severe.The main adverse reaction was allergic reaction.The adverse reaction also happened in digestive system,nervous system and the hematological system.All the patients recovered by withdrawing the decoction and taking symptomatic treatment.Conclusion: TCM decoction can cause adverse reaction,even sometimes cause the severe reaction.Mueti-means and comprehensive analysis can help us to judge the right medicine which bring the adverse reaction and make the judgment more scientifically and accurately.
Analysis of the Questions in the Criterion of Action for Injection of Traditional Chinese Medicine

Bai Xiao-ju,Zhang Zhi-fen,Yu Ni-na,Liu Xing-chang

DOI: https://doi.org/10.3969/j.issn.1009-3656.2009.02.009

2009-01-01

Abstract:By studying the government criterions of 124 Traditional Chinese Medicine(TCM)injections in China,to discuss the functions of TCM injections in 4 aspects,the overview of the form of expression,the goals and significance of the regulation of the functio-ns of TCM injections,and the basic principle and specific requirement of regulation.So as to improve the criterions and to regulate the instructions of TCM injections,and then to prompt the development of TCM injections rapidly and stablely.
[Strategy of constructing post-market integral evaluation system of traditional Chinese medicine injection]

Xiao-Yu Zhang,Yan-Ping Wang,Li-Kai Lin,Hong-Cai Shang,Yong-Yan Wang

DOI: https://doi.org/10.19540/j.cnki.cjcmm.20170623.007

Abstract:As an important representative of modern Chinese medicine, traditional Chinese medicine (TCM) injzection has become an indispensable part of the Chinese medicine industry. However, its development is now restricted by the bottleneck of insufficient core competitiveness, low-level research and production, even injection quality and the safe use are not guaranteed. Thus, it is urgent to reevaluate post-marketing TCM injection generally and to make secondary development. Under current circumstances, taking major brands which have good clinical and market foundation, as well as research value, as the main subject of cultivation and evaluation is an important approach to innovative development of TCM injection industry. Unlike oral proprietary Chinese medicine, the cultivatation of major brands of TCM injection needs higher technical support, quality standards and more timely feedback. Therefore, a post-market integral evaluation system adaptive to TCM injection is required. This article discussed some key points on the construction of a post-market integral evaluation system of TCM injection in three levels： optimizing evaluation methods, building synergistic innovation platforms which combine the medical research institutions and pharmaceutical enterprises, and finally constructing the integral evaluation system. A "five to one" structure has been proposed to enhance TCM injection effectiveness, safety and adaptability on the whole, which are from the following aspects： mechanism research, clinical evidence validation, literature information mining, sustainable development of resources and industrialization operation.
Reasonable Application in the Heart and Cerebrovascular Diseases of Chinese Medicine Injection

Qi Guo,Xianghui Qi

DOI: https://doi.org/10.1109/hhbe.2011.6028964

2011-01-01

Abstract:Traditional Chinese medicine injection (TCM injection) basing on the traditional Chinese medicine theory is made from the extraction of effective material of natural medicine unilateral or compound by using modern scientific techniques and methods. During the course of the experience medicine transforming into the evidence-based medicine, TCM injection must prove its efficacy and safety by evidence-based medicine so that it can be better accepted by the majority of clinicians and plays its important clinical Value. Therefore, in-depth study of TCM injection used in cardiovascular and cerebrovascular diseases is of great significance in rational clinical drug use.
Analysis of Reports of ADR Caused by Shenmai Injection

Fang Jing

DOI: https://doi.org/10.3969/j.issn.1006-2882.2007.02.018

2007-01-01

Abstract:Objective:To analyze the factors of ADR caused by shenmai injection and the prevention and cure measures so as to offer basis for the clinic in the rational use of drugs.Methods:ADR casesed by shenmai Injection of all Peking University Shenzhen Hospital inpationts reported form 2004 to 2006 were analyzed retraspectively.Results: shenmai injection could induce the dermatology system reaction.Conclusion:Clinicians should know the characteristics of adverse reactions induced by shenmai injection so as to apply it rationally.
[Reevaluation for systematic reviews for traditional Chinese medicine injections for coronary disease]

Xiu-Ping Yin,Yan-Ming Xie,Xing Liao,Man Luo

DOI: https://doi.org/10.4268/cjcmm20162228

Abstract:To reevaluate the systematic reviews for traditional Chinese medicine(TCM) injections for treating coronary disease, data in four Chinese databases and PubMed, Embase, Cochrane Library, Wed of Science OVID from inception until May 2016 were searched. We extracted data according to the AMSTAR and PRISMA checklists to evaluate the methodological quality and reporting characteristics of included literatures. A total of 69 systematic reviews were included, involving 24 TCM injections, which showed certain efficacy in treating coronary disease, and whose main outcome indexes included alleviation of symptoms of angina pectoris and electrocardiogram. In all of the systematic reviews, the duration of follow-up were not reported. Six systematic reviews reported TCM typing. In the 44 system reviews, 1 335 reports mentioned 4 137 adverse events. According to the results of AMSTAR and PRISMA checklists, the quality assessment scores about included studies were not high, and most of the systematic reviews suffered heterogeneity and irrational processing of forest plots. In conclusion, TCM injections in the treatment of coronary disease have a wide range and positive effects. However, affected by the low quality of systematic reviews and the production of reevaluation, the study had some limitations. Therefore, the systematic reviews shall be further improved, in order to provide more advanced clinical evidences to clinicians.

Discussion on Drug Reevaluation by Analyzing Adverse Drug Reaction of Traditional Chinese Medicine Injection

[Analysis on the Common Causes for Traditional Chinese Medicinal Injection Induced Adverse Reactions and the Preventive Countermeasures].

[Retrospective Analysis and Discussion on 74 Cases of Adverse Reactions of Traditional Chinese Medicine Injection].

Thinking on Strengthening the Study of Adverse Drug Reaction of Traditional Chinese Medicine

Discriminant Analysis of "Q-Markers" of Traditional Chinese Medical Injections——Taking Dan Hong Injection as a Model

Discussion on Strengthening Management of Traditional Chinese Medicine Injection

["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations]

Advances in analytical techniques and quality control of traditional Chinese medicine injections

Implementation of Quality by Design in the Program of Safety Re-evaluation of TCM Injections

Analysis of 136 ADRs Induced by Chinese Patent Medicine

Discussion on the Factors Influencing the Safety of Injections

Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China

[Application status and safety countermeasures of traditional Chinese medicine injections]

Analysis and Discussion on Instruction of Traditional Chinese Medicine Injection

Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China

The Analysis and Evaluation of Adverse Reactions Caused by TCM Decoction

Analysis of the Questions in the Criterion of Action for Injection of Traditional Chinese Medicine

[Strategy of constructing post-market integral evaluation system of traditional Chinese medicine injection]

Reasonable Application in the Heart and Cerebrovascular Diseases of Chinese Medicine Injection

Analysis of Reports of ADR Caused by Shenmai Injection

[Reevaluation for systematic reviews for traditional Chinese medicine injections for coronary disease]